DNDN

Dendreon Corporation News Headlines

$2.15
*  
0.01
0.47%
Get DNDN Alerts
*Delayed - data as of Jul. 22, 2014 11:36 ET  -  Find a broker to begin trading DNDN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    DNDN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Dendreon Faces New Competition As J&J Impresses With Prostate Cancer Drug
3/11/2012 7:15:00 AM - Seeking Alpha

Breast Cancer Immunotherapy: A New Hope In The Fight
3/9/2012 8:57:00 AM - Seeking Alpha

Speculative Biotech For The Iron-Stomached
3/8/2012 5:46:00 PM - Seeking Alpha

Thursday Options Recap
3/8/2012 4:07:00 PM - Seeking Alpha

Dendreon's Provenge: Interview With Head, Large Urology Group Practice
3/8/2012 11:58:00 AM - Seeking Alpha

Immunocellular Touches $3 On Continued Speculation
3/7/2012 10:53:00 AM - Seeking Alpha

Top High Conviction Picks Of Biotech-Focused Baker Bros. $3.0 Billion 13-F Portfolio
3/7/2012 4:09:00 AM - Seeking Alpha

Immunocellular Thereapeutics: Pending Catalysts Could Spark Share Price Run
3/5/2012 11:08:00 AM - Seeking Alpha

In Spite Of Dendreon's Woes, Other Players In The Sector Are Starting To Roll
3/4/2012 12:30:00 PM - Seeking Alpha

Weekly Stock Watch: Feb 27-March 2
3/4/2012 6:25:00 AM - Seeking Alpha

FDA Approval Practically A Done Deal For Keryx And AEterna Zentaris
3/2/2012 5:19:00 PM - Seeking Alpha

Why I Remain Positive On Dendreon
3/2/2012 12:06:00 PM - Seeking Alpha

The Zacks Analyst Blog Highlights: Dendreon, Merck, Johnson & Johnson, Medivation and CONSOL Energy - Press Releases
3/1/2012 9:30:01 AM - Zacks.com

Deciding Between A 'Reverse Iron Condor' Or 'Strangle' Earnings Trade
3/1/2012 3:45:00 AM - Seeking Alpha

Dendreon's Woes Mask The Exciting Opportunities In Immunotherapy Companies
3/1/2012 2:51:00 AM - Seeking Alpha

Bleak Outlook for Dendreon's Provenge - Analyst Blog
2/29/2012 4:30:01 PM - Zacks.com

4 Outperforming Biotech Stocks with Bullish Short Trends
2/29/2012 3:42:00 PM - Seeking Alpha

Top Q4 Picks Of The World's Largest Healthcare Investment Firm, Orbimed Advisors
2/28/2012 2:46:00 AM - Seeking Alpha

VIX - Options Volatility Sonar: Monday Recap
2/27/2012 5:39:00 PM - Seeking Alpha

Monday Options Recap
2/27/2012 3:37:00 PM - Seeking Alpha

Stocks Set to Pare Gains as G-20 Defers on Europe Aid
2/27/2012 9:40:11 AM - Schaeffer's Investment Research

Rethinking Immunotherapy For Brain Tumors
2/24/2012 4:09:00 PM - Seeking Alpha

5 More Stocks That Could Collapse In 2012
2/23/2012 10:29:00 AM - Seeking Alpha

Dendreon: Overall Survival Data For Provenge From 2012 GU Poster
2/17/2012 10:27:00 AM - Seeking Alpha

How Obama's FDA Directive Should Benefit Biopharma
2/16/2012 11:51:00 AM - Seeking Alpha